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ABSTRACT 27 
Peripheral arterial disease (PAD) is characterized by stenosis and occlusion of the lower limb 28 
arteries. While leg blood flow is limited in PAD, it remains unclear whether skeletal muscle 29 
microvascular perfusion is affected. We compared whole-leg blood flow and calf muscle 30 
microvascular perfusion following cuff occlusion and submaximal leg exercise between PAD 31 
patients (n=12, 69±9 years) and healthy age-matched control participants (n=12, 68±7 years). 32 
Microvascular blood flow (microvascular volume x flow velocity) of the medial 33 
gastrocnemius muscle was measured before and immediately after: 1) 5 min of thigh-cuff 34 
occlusion; and 2) a 5-min bout of intermittent isometric plantar-flexion exercise (400N) using 35 
real-time contrast-enhanced ultrasound (CEU). Whole-leg blood flow was measured after 36 
thigh-cuff occlusion and during submaximal plantar-flexion exercise using strain-gauge 37 
plethysmography. Post-occlusion whole-leg blood flow and calf muscle microvascular 38 
perfusion were lower in PAD patients than controls, and these parameters were strongly 39 
correlated (r=0.84; p<0.01). During submaximal exercise, total whole-leg blood flow and 40 
vascular conductance were not different between groups. There were also no group 41 
differences in post-exercise calf muscle microvascular perfusion, although microvascular 42 
blood volume was higher in PAD patients than control (12.41±6.98 vs 6.34±4.98 aU; p=0.03). 43 
This study demonstrates that the impaired muscle perfusion of PAD patients during post-44 
occlusion hyperemia is strongly correlated with disease severity, and is likely mainly 45 
determined by the limited conduit artery flow. In response to submaximal leg exercise, 46 
microvascular flow volume was elevated in PAD patients, which may reflect a compensatory 47 
mechanism to maintain muscle perfusion and oxygen delivery during recovery from exercise.  48 
 49 
KEYWORDS: Peripheral arterial disease, skeletal muscle, microcirculation, reactive 50 
hyperemia, exercise, ultrasound. 51 
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 52 
NEW AND NOTEWORTHY 53 
This study suggests that PAD has different effects on the microvascular perfusion 54 
responses to cuff occlusion and submaximal leg exercise. PAD patients have impaired 55 
microvascular perfusion following cuff occlusion, similar to that previously reported 56 
following maximal exercise. In response to submaximal exercise, however, the microvascular 57 
flow volume response was elevated in PAD patients compared with control. This finding may 58 
reflect a compensatory mechanism to maintain perfusion and oxygen delivery during 59 
recovery from exercise. 60 
 61 
INTRODUCTION 62 
Peripheral arterial disease (PAD) is an atherosclerotic disease characterized by 63 
stenosis or occlusion of the conduit arteries of the lower limbs. PAD is associated with severe 64 
exercise intolerance (2), which cannot be fully explained by hemodynamic impairments. 65 
Patients with PAD have impaired endothelial function (4), and alterations in their skeletal 66 
muscle phenotype that likely contribute to their exercise intolerance (2, 25). There have been 67 
some reports that skeletal muscle capillarization is reduced in PAD patients (2, 25, 26), and 68 
positively correlated to exercise capacity in these patients (2, 26). There are, however, some 69 
contrasting reports that muscle capillarization is similar (10), or even greater in PAD patients 70 
(20) than controls. It is therefore unclear what effect PAD has on microvascular structure and 71 
function, and in particular what role microvascular dysfunction plays in the exercise 72 
intolerance of PAD patients.  73 
Contrast-enhanced ultrasound (CEU) is widely used for the assessment of 74 
microvascular blood flow (perfusion) in various human tissue beds (29), and a limited 75 
number of studies have used this technique to assess leg muscle perfusion in PAD patients (1, 76 
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6, 7, 16, 18, 30). These studies have shown that PAD is associated with a reduction in peak 77 
muscle perfusion capacity in response to ischemic provocation tests, such as thigh-cuff 78 
occlusion (1), limiting (maximal pain) treadmill walking exercise (16), and relatively high-79 
intensity (20 W) plantar-flexion exercise (6). These studies of peak perfusion responses 80 
demonstrate the strong diagnostic potential of CEU and the ability to discriminate between 81 
people with and without PAD. However, as CEU provides a measure of end-organ (i.e. 82 
muscle) perfusion, it is not clear to what extent the limited perfusion responses in PAD 83 
patients can be attributed to a microvascular impairment or the impaired upstream conduit 84 
artery flow due to stenosis or occlusion.  85 
In order to distinguish the microvascular from the conduit artery contribution, it is 86 
important to consider whole-leg blood flow when interpreting microvascular perfusion 87 
responses, which has not been considered in previous studies of PAD patients (1, 6, 7, 16, 18, 88 
30). Whole-limb (33) and muscle microvascular blood flow (6) are generally not limited in 89 
PAD patients with intermittent claudication under resting conditions, and it is not until 90 
exercise is performed that a limit in blood flow is revealed. For a given patient, the point at 91 
which this limit is reached depends on the intensity of exercise, and patients usually self-92 
select low, submaximal intensities to carry out activities of daily living (9). It is likely that the 93 
limit in peak muscle perfusion reported in previous studies was due to the relatively high 94 
exercise intensities used, at which point conduit artery blood flow limits are achieved. To 95 
better understand the microvascular perfusion limit as it applies to typical activities of daily 96 
living, and to better distinguish the microvascular blood flow limit associated with PAD, 97 
there is a need for further studies. Specifically, an investigation of the microvascular 98 
perfusion in conjunction with whole-limb blood flow, in response to submaximal exercise 99 
conditions that can be sustained within the symptomatic and hemodynamic limits of patients.  100 
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Therefore, the primary aim of this study was to compare calf muscle microvascular 101 
perfusion following cuff occlusion and submaximal leg exercise between PAD patients and 102 
control participants using continuous real-time CEU imaging, and also to assess whole-limb 103 
blood flow and its relationship with the muscle perfusion responses.  104 
 105 
METHODS 106 
Participant recruitment 107 
Twelve patients with PAD and symptoms of intermittent claudication and 12 healthy 108 
control participants were recruited to take part in this study. Participants that were current 109 
smokers, had uncontrolled hypertension, unstable angina, congestive heart failure or critical 110 
limb ischemia were excluded. PAD patients unable to complete the 5-min leg exercise test 111 
due to intolerable calf muscle pain were also excluded. All participants gave written informed 112 
consent to participate in the study, which was approved by the Prince Charles Hospital 113 
(HREC/14/QPCH/122) and University of the Sunshine Coast (A/15/706) Human Research 114 
Ethics Committees. All procedures were conducted in accordance with the Declaration of 115 
Helsinki.  116 
 117 
Study overview 118 
Participants initially underwent screening and baseline measures, and completed a 119 
seven-day physical activity recall (3). Resting ankle-brachial index (ABI) of each leg was 120 
measured, and estimated calf muscle mass was determined using established anthropometric 121 
measures (5). Participants were familiarized with the plantar-flexion exercise protocol and 122 
performed a maximum force test. Participants attended an experimental session (session 1) 123 
for the assessment of whole-leg blood flow at rest and following thigh-cuff occlusion using 124 
strain-gauge plethysmography. Then, contraction-by-contraction whole-leg blood flow was 125 
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recorded during a 5-min bout of intermittent isometric plantar-flexion exercise. Exercise was 126 
submaximal and conducted at the same absolute (400 N) and relative (60±18% maximum 127 
force) intensity in both groups. Participants attended two further experimental sessions, on 128 
separate days, where muscle microvascular perfusion of the medial gastrocnemius was 129 
assessed using CEU before and after 5-min of thigh-cuff occlusion (session 2), and before 130 
and after the same 5-min plantar-flexion exercise protocol (session 3). Within each session, 131 
test procedures were conducted twice, separated by 15 min, and average responses were used 132 
for analysis. The non-dominant leg of the control participants, and the leg with the lowest 133 
ABI of PAD patients was assessed. Sessions were conducted at the same time of day, ~72 h 134 
apart, and participants were instructed to avoid exercise and caffeine or alcohol consumption 135 
for 24 h before each session.  136 
 137 
Plantar-flexion exercise  138 
Participants performed isometric plantar-flexion contractions in the seated position 139 
with their foot on an immovable footplate. A calibrated load cell (Xtran S1W, Applied 140 
Measurement, Melbourne, Australia) was positioned over the distal thigh, and contraction 141 
force was displayed on a monitor. After familiarization, participants performed five 142 
maximum voluntary contractions (MVC), each separated by 60 s rest, and the average was 143 
used as the maximum force. The 5-min bouts of plantar-flexion exercise were performed at a 144 
fixed contraction intensity of 400 N (contraction:relaxation duty cycle: 2:3 s). After each 145 
exercise bout participants were instructed to rate their exercise-associated calf muscle pain as 146 
“no pain”, “mild pain”, “moderate pain” or “maximal pain”. 147 
 148 
Whole-leg blood flow  149 
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Whole-leg blood flow was assessed using strain-gauge plethysmography (EC6 150 
Plethysmograph, Hokanson, Bellevue, USA). A rapid inflation cuff (Hokanson, Bellevue, 151 
USA) was placed around the upper thigh, and a mercury-in-silastic strain gauge was placed 152 
around the calf at the largest circumference. Measurements were performed during supine 153 
rest and following five min of thigh-cuff occlusion at a pressure of 200 mmHg, as previously 154 
described (14).  155 
Contraction-by-contraction leg blood flow was measured throughout exercise as 156 
previously described (23). Blood flow was assessed following each contraction as the change 157 
in limb volume over the first cardiac cycle, free of movement artefact, from the onset of the 158 
3-s relaxation phase. Single lead electrocardiogram, heart rate (ADInstruments, Sydney, 159 
Australia) and beat-by-beat finger blood pressure (Finapres Medical Systems, the 160 
Netherlands) were continuously monitored during exercise. Leg vascular conductance was 161 
calculated at rest and during exercise as leg blood flow divided by mean arterial pressure. 162 
Contraction-by-contraction whole-leg blood flow and vascular conductance were averaged 163 
across the repeated within-session trials and fitted to a biphasic exponential response curve 164 
(Table Curve 2D v4, SPSS, Illinois, USA) to determine the total rise in whole-leg blood flow 165 
during exercise (23). The goodness of fits for the whole-leg blood flow (n=24) and vascular 166 
conductance data (n=24), based on the adjusted R
2
, were 0.77±0.12 and 0.73±0.15, 167 
respectively. 168 
 169 
Calf muscle microvascular perfusion 170 
Calf muscle microvascular perfusion was measured using CEU. Images were obtained 171 
from the medial gastrocnemius muscle at the point of the greatest leg circumference, with the 172 
ultrasound transducer secured to the leg using a foam holder. Continuous harmonic power-173 
Doppler imaging (Philips Diagnostic Ultrasound Systems model iE33, Philips Medical 174 
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Systems, Andover, USA) was performed with a linear-array transducer (Philips L9-3), using 175 
a low mechanical index (0.10), 87% gain and 5 cm depth. Contrast solution consisting of 1.5 176 
mL of lipid shelled octafluoropropane microbubbles (Definity, Bristol-Myers Squibb Medical 177 
Imaging, New York, USA) mixed to 50mL with saline was infused intravenously (antecubital 178 
fossa) at a constant rate of 200 mL/hour, using a syringe pump (Alaris PK, Auckland, New 179 
Zealand) that was continuously mechanically rocked to prevent agent sedimentation. Each 180 
CEU measurement required a total of three min of contrast microbubble infusion, with the 181 
first two min of infusion required to achieve a steady-state concentration of microbubbles. 182 
This was followed by a pulse of high-energy ultrasound (mechanical index = 1.07) for 183 
microbubble destruction, and at least 50 s (range 50-60 s) of image acquisition to assess the 184 
kinetics of microbubble replenishment. Examples of original CEU images are presented in 185 
Figure 1. 186 
 187 
Microvascular image analysis 188 
QLAB software (Philips Healthcare, Bothell, USA) was used to generate time-189 
intensity curves for analysis of replenishment kinetics. An examiner (A.L.M.) manually 190 
selected a representative quadrilateral region of interest (839±163 mm
2
) encompassing the 191 
medial gastrocnemius muscle that was automatically transposed for repeated measurements. 192 
Time-intensity data were exported for background subtraction (Excel 15.0, Microsoft 193 
Corporation), where the background intensity was set at 0.98 s (resting data) or 0.49 s (cuff 194 
occlusion and exercise data) from the moment of bubble-destruction to exclude the 195 
contributions of the faster-filling, larger non-capillary vessels from the background signal 196 
intensity (27). Using a 3-s moving average, we identified the time-to-peak acoustic intensity 197 
as the duration from the onset of change in microbubble acoustic intensity after microbubble 198 
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destruction until its peak. The area under the curve was calculated as the total accumulated 199 
change in acoustic intensity during the first 50 s following cuff occlusion or exercise. 200 
Averaged time-intensity data from repeat trials were fitted to an exponential function 201 
y=A[1-exp
-βt
] for the analysis of the time-intensity curves, where: y is the video intensity at 202 
time t (in seconds); A is the peak video intensity, which estimates microvascular blood 203 
volume; and β is the rate of appearance of the microbubbles (i.e. the rate constant), which 204 
estimates microvascular flow velocity (35). Skeletal muscle microvascular blood flow 205 
(perfusion) was calculated as the product of blood volume multiplied by velocity (A*β). 206 
Curve fitting was performed using Sigmaplot software version 13.0 (Systat Software, San 207 
Jose, USA). The adjusted R
2
 for the CEU microvascular blood flow (n=24) data was 208 
0.92±0.10. The within-session intra-class correlation coefficient indicated an excellent 209 
reliability of measurements of muscle microvascular perfusion (n=24) obtained with CEU 210 
under resting conditions (0.91 [95% CI 0.83-0.96]) and in response to cuff occlusion (0.96 211 
[95% CI 0.91-0.99]) and exercise (0.95 [95% CI 0.88-0.98]) (8). 212 
 213 
Statistical analysis  214 
Skeletal muscle microvascular perfusion was the primary outcome of interest and 215 
therefore a priori sample size calculations were performed based on the mean of previously 216 
reported differences between PAD patients and controls for reactive hyperemia and exercise 217 
(10±4 and 10±9 aU.s
-1
, respectively) (18, 31). Assuming a power of 80% and an alpha level 218 
of 0.05, a minimum sample size of 6-11 participants in each group was required to detect 219 
these differences.  220 
The Gaussian distribution and homogeneity of variance of the data were confirmed 221 
using Shapiro Wilk and Levene tests. Baseline comparisons were performed using 222 
independent sample t-tests and chi-square tests for continuous and categorical variables, 223 
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respectively. Whole-leg blood flow and microvascular perfusion parameters were analyzed 224 
using a 2-way (group x time) mixed ANOVA, followed by Tukey’s post-hoc test when there 225 
were significant main effects or interactions. Correlations were assessed using Pearson´s 226 
correlation coefficient. P<0.05 was considered statistically significant. Statistical analyses 227 
were performed using SPSS version 22.0 for Windows and power calculations were 228 
performed using GPower version 3.1. Data are presented as mean and standard deviation (SD) 229 
unless stated otherwise.  230 
 231 
RESULTS 232 
Participant characteristics 233 
Participant characteristics are shown in Table 1. Five PAD patients (42%) had arterial 234 
stenoses or occlusions in multiple artery segments, while the remaining patients had 235 
significant unilateral or bilateral stenoses or occlusions in the aorto-iliac (n=2; 17%), femoral 236 
(n=4; 33%) or popliteal (n=1; 8%) segments. Self-reported habitual physical activity levels 237 
tended to be lower in PAD patients but were not significantly different between groups (PAD: 238 
1.6±1.6; Control: 2.8±2.2 h/week; p=0.16).  239 
***INSERT TABLE 1*** 240 
 241 
Plantar-flexion force 242 
Plantar-flexion MVC force was not significantly different between groups, meaning 243 
that the relative intensity of the target force during the bouts of plantar-flexion exercise was 244 
not different between groups (Table 1). The results remained unchanged after correcting 245 
MVC force for estimated calf muscle mass. The 5-min submaximal exercise bouts were well 246 
tolerated by all control participants, and 11 of the 12 PAD patients (92%) reported moderate 247 
to maximal calf muscle pain towards the end of the tests.  248 
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 249 
Post-occlusion whole-leg blood flow and vascular conductance 250 
Baseline (supine rest) whole-leg blood flow and vascular conductance were not 251 
significantly different between groups (Table 2). Post-occlusion whole-leg blood flow and 252 
vascular conductance were significantly lower in PAD patients compared with controls 253 
(Table 2). 254 
***INSERT TABLE 2*** 255 
 256 
Post-occlusion calf muscle microvascular perfusion  257 
Mean CEU time-intensity curves following cuff occlusion in PAD patients and 258 
controls are shown in Figure 2. Time-to-peak acoustic intensity was longer in PAD patients 259 
(41.15±12.37 s, p<0.01) compared with controls (17.79±3.98 s). Area under the response 260 
curve tended to be lower in the PAD group compared to controls, but the difference was not 261 
statistically significant (PAD: 413±343; Control: 659±452 aU.s; p=0.08). 262 
Calf muscle microvascular perfusion parameters, at baseline and following cuff 263 
occlusion, are shown in Figure 3. Baseline (pre-occlusion) muscle microvascular blood 264 
volume, flow velocity and perfusion were not significantly different between groups (p>0.05). 265 
In comparison with baseline, post-occlusion microvascular blood volume increased (p<0.01; 266 
Figure 3A) in both groups, and despite the slower rise (Figure 2), peak volume in the PAD 267 
group was not significantly different to controls (p=0.14, Figure 3A). Post-occlusion 268 
microvascular flow velocity increased in controls (p<0.01; Figure 3B), but did not change 269 
significantly in PAD patients (p=0.29), resulting in a lower microvascular perfusion response 270 
in PAD patients than in controls (p<0.01; Figure 3C).  271 
***INSERT FIGURE 2*** 272 
***INSERT FIGURE 3*** 273 
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 274 
Exercise whole-leg blood flow and vascular conductance 275 
Baseline (seated rest) whole-leg blood flow was not different between groups (p=0.43; 276 
Table 2). Total whole-leg blood flow during submaximal exercise was not significantly 277 
different between PAD patients and controls (p=0.10; Table 2). Results remained unchanged 278 
when differences in blood pressure between groups were accounted for by expressing the 279 
blood flow responses as leg vascular conductance (p=0.75; Table 2). 280 
 281 
Post-exercise calf muscle microvascular perfusion  282 
The mean CEU time-intensity curves for the period immediately following 283 
submaximal plantar-flexion exercise in PAD patients and controls are shown in Figure 4. 284 
Time-to-peak acoustic intensity was not different between groups (PAD: 39.67±16.18; 285 
Control: 30.35±14.46 s; p=0.13). The area under the curve was greater in PAD patients 286 
(576±343 aU.s; p=0.01) than controls (264±224 aU.s). 287 
Calf muscle microvascular perfusion parameters, before and after submaximal 288 
exercise, are shown in Figure 5. Baseline (pre-exercise) microvascular parameters were not 289 
different between groups (p>0.05). Microvascular blood volume increased (p<0.01) with 290 
exercise in both groups, and was significantly higher in the post-exercise period in PAD 291 
patients than controls (p=0.03; Figure 5A). Microvascular flow velocity increased (p<0.01) 292 
with exercise in both groups, with no significant difference between PAD patients and 293 
controls (p=0.91; Figure 5B). Microvascular perfusion also increased (p<0.01) with exercise 294 
in both groups, with no significant difference between PAD patients and controls (p=0.35; 295 
Figure 5C).  296 
***INSERT FIGURE 4*** 297 
***INSERT FIGURE 5*** 298 
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 299 
Relationships between variables 300 
ABI was significantly correlated with muscle microvascular blood volume (n=24; 301 
r=0.41; p=0.04), flow velocity (n=24; r=0.80; p<0.01) and perfusion (n=24; r=0.67; p<0.01). 302 
Post-occlusion whole-leg blood flow was significantly correlated with muscle microvascular 303 
blood volume (n=24; r=0.58; p<0.01), flow velocity (n=24; r=0.76; p<0.01) and perfusion 304 
(n=24; r=0.84; p<0.01). All correlations remained significant when whole-leg blood flow was 305 
expressed as leg vascular conductance (p<0.05). However, these correlations were not 306 
significant when considering PAD and control groups separately. There were no significant 307 
correlations between post-exercise CEU microvascular parameters and ABI or whole-leg 308 
blood flow.  309 
 310 
DISCUSSION 311 
Previous studies that have reported reductions in muscle microvascular perfusion 312 
capacity in PAD patients in response to cuff occlusion and exercise have not reported whole-313 
leg or conduit artery blood flow. Consequently it was not known whether the microvascular 314 
perfusion limitation merely reflected the limited (stenotic) arterial flow capacity. Moreover, it 315 
was not known whether muscle microvascular perfusion was limited in PAD patients during 316 
submaximal exercise, at workloads that reflect activities of daily living and that are able to be 317 
sustained within the symptomatic and hemodynamic limits of the patient. This study 318 
demonstrated that: (i) post-occlusion whole-leg blood flow and calf muscle microvascular 319 
perfusion were lower in PAD patients compared with controls, and these parameters were 320 
strongly correlated; and (ii) in response to submaximal plantar-flexion exercise, PAD patients 321 
exhibited similar whole-leg and post-exercise muscle microvascular perfusion responses 322 
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compared with controls, but muscle microvascular perfusion was achieved through a greater 323 
increase in microvascular volume in PAD patients. 324 
We found that calf muscle microvascular perfusion following 5-min of cuff occlusion 325 
was impaired in PAD patients. Post-occlusion time-to-peak acoustic intensity was longer in 326 
PAD patients than controls, which verifies the findings of a previous CEU study by 327 
Amarteifio et al. (1), and is consistent with the perfusion limit reported in studies of PAD 328 
patients using magnetic resonance imaging (19, 31). In healthy individuals, post-occlusion 329 
reactive hyperemia is predominantly determined by vascular resistance at the level of the 330 
microvessels (28), whereas in PAD patients the conduit artery resistance at the site of the 331 
arterial stenosis also likely contributes to the hyperemic response. In the present study, the 332 
impairment in post-occlusion hyperemia in PAD patients was evident throughout the vascular 333 
tree, with lower whole-leg blood flow and calf muscle microvascular perfusion compared 334 
with controls. The lower post-occlusion microvascular perfusion in PAD patients was mainly 335 
attributable to a lower microvascular flow velocity (parameter β) compared with controls. 336 
Therefore, microvascular flow velocity might be determined by limb blood flow or perfusion 337 
pressure, and this is supported by the strong correlation between microvascular flow velocity 338 
and whole-leg blood flow. While previous findings of an impaired post-occlusion CEU 339 
response in PAD patients have been attributed to a microvascular impairment (1), our 340 
findings suggest that the low post-occlusion microvascular flow velocity may largely reflect 341 
disease severity and the impaired whole-limb blood flow response. This is further supported 342 
by the strong relationship between ABI and the post-occlusion microvascular velocity and 343 
whole-leg blood flow parameters observed in the current study. 344 
During tightly matched submaximal plantar-flexion exercise at the same absolute 345 
(400N = ~8W) and relative (60±18% maximum force) intensity, steady-state whole-leg blood 346 
flow did not differ between PAD patients and controls. Patients were able to sustain this 347 
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exercise for 5 min, indicating that the intensity was within their hemodynamic and 348 
symptomatic limits, and at a level that is typical of their daily activities (9). In response to 349 
this level of exercise we found that post-exercise calf muscle microvascular perfusion is 350 
preserved in PAD patients and did not differ compared with healthy control participants. 351 
From this we assume that the observed microvascular responses are largely independent of 352 
whole-limb blood flow. In healthy individuals it has previously been shown that exercise-353 
induced microvascular hyperemia is accompanied by changes in total limb blood flow at 354 
higher (80% max) but not lower (25% max) exercise intensities (32). It was therefore 355 
suggested that perfusion at lower exercise intensities is regulated through a localized 356 
redistribution of blood flow, possibly at the level of the terminal arterioles, and with more 357 
intense exercise there are also changes in the upstream resistance of the arteriolar network 358 
with consequent changes in total limb blood flow (32). Whether maximal exercise-induced 359 
muscle ischemia in PAD patients might disrupt this relationship cannot be determined in this 360 
study as the exercise test was submaximal and within the limits of patients; however, it is 361 
notable that there was no significant relationship between exercise whole-leg blood flow and 362 
post-exercise muscle microvascular perfusion in PAD patients and controls.  363 
While muscle perfusion responses to submaximal exercise did not differ between 364 
groups, an important finding was that the increase in perfusion relied on a larger increase in 365 
microvascular volume (parameter A) in PAD patients compared with controls. The increased 366 
microvascular volume, characterized by an increase in CEU microbubble density, may reflect 367 
a reduction in microvascular resistance and a redistribution of blood flow within the working 368 
skeletal muscle. It has also been suggested that an increase in microvascular volume may 369 
reflect de-novo recruitment of previously non-flowing capillaries (21), although this is 370 
debatable (24). In PAD patients, the increased microvascular volume may serve to enhance 371 
capillary flow and the endothelial surface area available to support the delivery of oxygen and 372 
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nutrients to myocytes (24), and therefore compensate for microvascular flow velocity, which 373 
tended to be lower in PAD patients compared to controls. Similar compensatory responses 374 
have been reported in ischemic heart studies using CEU, where myocardial microvascular 375 
perfusion is maintained with increasing coronary artery stenosis severity via increases in 376 
microvascular blood volume (17).  377 
Recent studies by Kundi et al. 2017 (16) and Davidson et al. 2017 (6) have 378 
demonstrated the clinical utility of CEU to differentiate between individuals with and without 379 
PAD on the basis of peak exercise muscle perfusion. Their findings of a lower peak muscle 380 
perfusion response, compared with controls, to (maximal) limiting treadmill walking (16) and 381 
a short bout (2 min) of high-intensity (~20 W) plantar-flexion exercise (6), provide support 382 
for the use of peak exercise CEU responses in the diagnosis of PAD. The exercise intensity 383 
used in those studies was not well matched between groups (16) and was notably higher than 384 
the submaximal intensity used in the present study (400 N, ~8 W). At these higher intensities, 385 
patients were likely working at a level above their conduit artery blood flow limit, which is 386 
reflected in the lower (end-organ) muscle perfusion relative to controls. This cannot be 387 
directly verified as those studies did not include measures of whole-limb or conduit artery 388 
blood flow, as was done in the present study. However, in a subgroup of PAD patients in the 389 
study by Davidson et al. 2017 (6) who underwent surgical revascularization to restore conduit 390 
artery blood flow, there was a marked increase in the muscle perfusion response to exercise. 391 
This suggests that at this relatively high exercise intensity (20 W), the muscle perfusion 392 
response is largely determined by the conduit artery flow limit in PAD patients, and this 393 
response would be expected to be exacerbated in patients with more severe disease (e.g. ABI 394 
< 0.6), such as those in the study by Davidson et al. (6).  395 
We used real-time CEU imaging in conjunction with a continuous infusion of the 396 
microbubble contrast agent, which has not been done in previous studies of PAD patients. 397 
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This method enables the assessment of rapid changes in muscle microvascular flow, such as 398 
during the period immediately following exercise. The incremental imaging approach used by 399 
Davidson et al. 2017 (6) and the bolus infusion approach used by Kundi et al. 2017 (16) are 400 
limited to use under steady-state conditions, and are therefore not ideally suited to studies of 401 
short periods of exercise (2 min) (6) and exercise recovery (16). Our study groups were well 402 
matched for age, whereas the mean age of the control groups in previous studies were 15-23 403 
years younger than the PAD groups (6, 16). In addition, there was a high proportion (89%) of 404 
diabetic patients in the PAD group of the study by Davidson et al. 2017 (6). Given the known 405 
influence of age (13, 15) and diabetes (27) on muscle microvascular structure and function, 406 
these factors are important to control for in studies of PAD. Patients with uncontrolled 407 
hypertension were not considered for the present study because of the known association 408 
between high blood pressure and capillary rarefaction (11). Blood pressure tended to be lower 409 
(not significant) in PAD patients at rest and during exercise, which we attribute to the greater 410 
use of anti-hypertensive medications in that group. 411 
Using real-time CEU, we have shown that PAD has a significant effect on the muscle 412 
microvascular perfusion responses to cuff-induced ischemia and submaximal exercise. 413 
Further research is needed to understand the mechanisms responsible for these responses, and 414 
specifically to determine to what extent the microvascular perfusion alterations in PAD are 415 
associated with changes in capillary density and structure. Future studies should test the 416 
effect of exercise intensity (e.g. maximal vs submaximal intensities) to better understand the 417 
influence on conduit artery flow and microvascular responses, and determine whether CEU 418 
derived measures of microvascular volume reflect muscle capillary supply, as has been 419 
proposed (34). There is also an opportunity for future research to focus on microvascular 420 
function as a treatment target in PAD patients. Adding exercise as an adjunct therapy 421 
following lower-limb surgical or endovascular revascularization for PAD promotes additional 422 
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improvements in symptoms and exercise capacity (22). Computational modelling of the PAD 423 
vasculature suggest that these gains are partially dependent on improvements in 424 
microvascular function (12), however this has yet to be confirmed.  425 
Limitations of this study include the relatively small study sample, which might have 426 
contributed to the failure to detect significant differences in some secondary outcomes, such 427 
as AUC of the image intensity response. Nevertheless, this study was adequately powered to 428 
detect differences in our primary outcome of muscle microvascular perfusion. The study 429 
sample did not allow for subgroup analysis of variables that could possibly affect calf muscle 430 
microvascular perfusion, such as cardiovascular risk factors, medication use and site of 431 
stenosis. Additionally, it was not possible to make simultaneous measurements of whole-leg 432 
blood flow and calf muscle microvascular perfusion, which would provide a better indication 433 
of the role of whole-leg blood flow in determining microvascular perfusion responses to 434 
exercise.  435 
This study suggests that the impaired muscle perfusion of PAD patients during post-436 
occlusion hyperemia is strongly associated with disease severity, and is likely determined by 437 
the limited conduit artery flow. In response to submaximal leg exercise, muscle 438 
microvascular flow volume was elevated in PAD patients, which may reflect a compensatory 439 
mechanism to maintain perfusion and oxygen delivery during recovery from exercise. This 440 
study has highlighted novel alterations in microvascular flow that are likely to be of 441 
functional relevance in PAD patients and contribute to their capacity to undertake activities 442 
of daily living. Further research is required to understand the mechanism responsible for 443 
these findings and the impact of treatments, such as lower limb revascularization and exercise 444 
therapy, on muscle microvascular perfusion.  445 
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FIGURE LEGENDS 575 
 576 
Figure 1. Representative presentation of original CEU images from PAD and control 577 
participants at baseline and during peak microvascular perfusion following cuff occlusion and 578 
submaximal plantar-flexion exercise. Post-occlusion peak acoustic intensity occurs earlier in 579 
the control compared to PAD participant. Post-exercise peak acoustic intensity occurs at a 580 
similar time in PAD and control participants, but seems to be enhanced in the patient with 581 
PAD despite similar submaximal workload performed by both participants. 582 
 583 
Figure 2. Post-occlusion CEU time-intensity curves in PAD patients (n=12; open circles) and 584 
controls (n=12; shaded circles). Data points represent group mean and error bars are SEM. 585 
 586 
Figure 3. Calf muscle microvascular blood volume (panel A), flow velocity (panel B) and 587 
perfusion (panel C) at baseline and following cuff occlusion in PAD patients (n=12) and 588 
controls (n=12). Values are mean and SD. Dotted lines indicate individual participant 589 
responses. *Significantly different from baseline (p<0.05); †Significantly different to control 590 
participants (p<0.05).  591 
 592 
Figure 4. Post-exercise CEU time-intensity curves in PAD patients (n=12; open circles) and 593 
controls (n=12; shaded circles). Data points represent group mean and error bars are SEM. 594 
 595 
Figure 5. Calf muscle microvascular blood volume (panel A), flow velocity (panel B) and 596 
perfusion (panel C) before and following plantar-flexion exercise in PAD patients (n=12) and 597 
controls (n=12). Values are mean and SD. Dotted lines indicate individual participant 598 
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responses. *Significantly different from baseline (p<0.05); †Significantly different to control 599 
participants (p<0.05). 600 
  601 
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TABLES 602 
Table 1. Participant characteristics.  603 
Parameter Control 
(n=12) 
PAD 
(n=12) 
P Value 
Age, y 68±7 69±9 0.72 
Male gender, n (%) 6 (50) 8 (67) 0.34 
Weight, kg 79.7±12.0 85.4±22.0 0.44 
Height, cm 172.3±7.0 170.6±7.5 0.57 
Body mass index, kg.m
-2
 26.9±4.0 29.1±6.1 0.32 
Resting ABI
a
 1.16±0.12 0.69±0.21 <0.01 
ECMM, kg 1.98±0.22 1.86±0.37 0.36 
Plantar-flexion MVC force, N 908±366 908±203 0.99 
Plantar-flexion MVC force, % MVC 63±22 58±13 0.40 
Plantar-flexion MVC force/ ECMM, N/kg 455±154 512±170 0.39 
Cardiovascular risk factors 
Previous-smoker, n (%) 2 (17) 10 (83) <0.01 
Dyslipidemia, n (%) 2 (17) 11 (92) <0.01 
Hypertension, n (%) 2 (17) 8 (67) 0.02 
Diabetes, n (%) 0 (0) 2 (17) 0.24 
History of coronary artery disease, n (%) 0 (0) 4 (33) 0.05 
Resting haemodynamics 
Heart rate, beats/min 61±9 63±10 0.55 
Systolic BP, mmHg 136±18 134±12 0.75 
Diastolic BP, mmHg 77±7 69±9 0.02 
Mean arterial pressure, mmHg 97±11 88±9 0.05 
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Blood Biochemistry 
Fasting glucose, mmol.L
-1
 5.16±0.37 6.48±1.72 <0.01 
Total cholesterol, mmol.L
-1
 5.73±0.74 4.28±0.93 <0.01 
LDL cholesterol, mmol.L
-1
 3.62±0.65 2.21±0.79 <0.01 
HDL cholesterol, mmol.L
-1
 1.53±0.45 1.35±0.38 0.31 
Triglycerides, mmol.L
-1
 1.33±0.94 1.53±1.01 0.67 
Medications 
Aspirin or clopidogrel, n (%) 2 (17) 9 (75) <0.01 
Beta blocker, n (%) 0 (0) 4 (33) 0.05 
ACE inhibitor or ARB, n (%) 2 (17) 9 (75) <0.01 
Statin, n (%) 2 (17) 11 (92) <0.01 
Calcium channel blocker, n (%) 2 (17) 4 (33) 0.32 
Metformin, n (%) 0 (0) 2 (17) 0.24 
Values are expressed as mean ± SD or n (%).  604 
ABI = ankle brachial index; ACE = angiotensin-converting enzyme inhibitor; ARB 605 
= angiotensin II receptor blocker; BP = blood pressure; ECMM = estimated calf 606 
muscle mass; HDL = high-density lipoprotein; LDL = low-density lipoprotein; 607 
MVC = maximum voluntary contraction; PAD = peripheral arterial disease. 608 
a 
ABI measured in the non-dominant limb of control participants, and in the more 609 
affected limb of PAD patients. 610 
 611 
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Table 2. Whole-leg blood flow and vascular conductance. 612 
Parameter Control (n=12) PAD (n=12) P value 
Post-occlusion measures (supine)    
Baseline blood flow, ml.100ml
-1
.min
-1
 1.94±0.65 2.10±0.78 0.61 
Baseline vascular conductance, ml.100ml
-1
.min
-1
.mmHg 0.02±0.01 0.02±0.01 0.33 
Post-occlusion blood flow, ml.100ml
-1
.min
-1
 16.55±6.02 4.52±3.59 <0.01 
Post-occlusion vascular conductance, ml.100ml
-1
.min
-1
.mmHg 0.18±0.07 0.05±0.04 <0.01 
Exercise measures (seated)    
Baseline blood flow, ml.100ml
-1
.min
-1
 1.73±0.95 2.04±0.89 0.43 
Baseline vascular conductance, ml.100ml
-1
.min
-1
.mmHg 0.02±0.01 0.02±0.02 0.90 
Exercise blood flow (plateau), ml.100ml
-1
.min
-1
 33.12±8.55 29.02±8.32 0.10 
Exercise vascular conductance (plateau), ml.100ml
-1
.min
-1
.mmHg 0.27±0.06 0.29±0.09 0.75 
Exercise mean arterial pressure, mmHg 117±22 108±16 0.15 
Exercise heart rate, beats/min 61±13 71±14 0.50 
Values are mean ± SD 613 
 614 
Downloaded from www.physiology.org/journal/ajpheart by ${individualUser.givenNames} ${individualUser.surname} (130.102.010.044) on August 13, 2018.
Copyright © 2018 American Physiological Society. All rights reserved.
Downloaded from www.physiology.org/journal/ajpheart by ${individualUser.givenNames} ${individualUser.surname} (130.102.010.044) on August 13, 2018.
Copyright © 2018 American Physiological Society. All rights reserved.
Downloaded from www.physiology.org/journal/ajpheart by ${individualUser.givenNames} ${individualUser.surname} (130.102.010.044) on August 13, 2018.
Copyright © 2018 American Physiological Society. All rights reserved.
Downloaded from www.physiology.org/journal/ajpheart by ${individualUser.givenNames} ${individualUser.surname} (130.102.010.044) on August 13, 2018.
Copyright © 2018 American Physiological Society. All rights reserved.
Downloaded from www.physiology.org/journal/ajpheart by ${individualUser.givenNames} ${individualUser.surname} (130.102.010.044) on August 13, 2018.
Copyright © 2018 American Physiological Society. All rights reserved.
Downloaded from www.physiology.org/journal/ajpheart by ${individualUser.givenNames} ${individualUser.surname} (130.102.010.044) on August 13, 2018.
Copyright © 2018 American Physiological Society. All rights reserved.
